ASML Holding N.V. New York Registry Shares (ASML)
Official siteTECHNOLOGY • SEMICONDUCTOR EQUIPMENT & MATERIALS • NASDAQ
Market Cap: $576.26B
Last updated: Nov 17, 2026 at 11:05 AM ET
ASML Holding N.V. New York Registry Shares (ASML) Financials: Revenue, Profit and Cash Flow
ASML Holding N.V. New York Registry Shares reported revenue of EUR 32.67B for the fiscal year ended Dec 31, 2025, up 15.6% from the year before. That year, net income was EUR 9.61B with a net margin of 29.4%, operating cash flow was EUR 12.66B and free cash flow was EUR 11.08B. The quarter ended Sep 30, 2026 had revenue of EUR 11.66B and net income of EUR 4.96B.
Revenue and Margins
The operating margin was 34.6% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from EUR 6.88B, a compound annual rate of 18.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 32.67B | +15.6% | 52.8% | 34.6% | 29.4% |
| Dec 2024 | 28.26B | +2.6% | 49.8% | 31.9% | 26.8% |
| Dec 2023 | 27.56B | +30.2% | 50.2% | 32.8% | 28.4% |
| Dec 2022 | 21.17B | +13.8% | 49.5% | 30.7% | 26.6% |
| Dec 2021 | 18.61B | +33.1% | 51.9% | 35.1% | 31.6% |
| Dec 2020 | 13.98B | +18.3% | 47.4% | 29.0% | 25.4% |
| Dec 2019 | 11.82B | +8.0% | 43.4% | 23.6% | 21.9% |
| Dec 2018 | 10.94B | +22.1% | 44.8% | 27.1% | 23.7% |
| Dec 2017 | 8.96B | +30.4% | 43.5% | 26.2% | 23.1% |
| Dec 2016 | 6.88B | N/A | 45.7% | 22.7% | 21.4% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 26.9% from the year before. In the quarter ended Sep 2026, net income rose 134.0% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32.67B | 28.26B | 27.56B | 21.17B | 18.61B | 13.98B | 11.82B | 10.94B | 8.96B | 6.88B |
| Cost of revenue | 15.41B | 14.18B | 13.72B | 10.70B | 8.96B | 7.35B | 6.69B | 6.05B | 5.06B | 3.73B |
| Gross profit | 17.26B | 14.08B | 13.84B | 10.47B | 9.65B | 6.63B | 5.13B | 4.90B | 3.90B | 3.15B |
| Research and development | 4.70B | 3.94B | 3.72B | 3.07B | 2.43B | 2.07B | 1.84B | 1.47B | 1.15B | 1.03B |
| Operating income | 11.30B | 9.02B | 9.04B | 6.50B | 6.54B | 4.05B | 2.79B | 2.97B | 2.34B | 1.56B |
| Net income | 9.61B | 7.57B | 7.84B | 5.62B | 5.88B | 3.55B | 2.59B | 2.59B | 2.07B | 1.47B |
| EBITDA | 12.43B | 10.11B | 10.02B | 7.10B | 7.23B | 4.55B | 3.25B | 3.40B | 2.86B | 2.09B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.66B | 9.33B | 8.77B | 9.72B | 7.52B | 7.52B | 7.69B | 7.74B | 9.26B | 7.47B | 6.24B | 5.29B |
| Gross profit | 6.70B | 5.04B | 4.64B | 5.07B | 3.88B | 3.88B | 4.13B | 4.18B | 4.79B | 3.79B | 3.21B | 2.70B |
| Operating income | 5.17B | 3.46B | 3.16B | 3.43B | 2.47B | 2.47B | 2.66B | 2.74B | 3.36B | 2.44B | 1.83B | 1.39B |
| Net income | 4.96B | 2.92B | 2.76B | 2.84B | 2.12B | 2.12B | 2.29B | 2.35B | 2.69B | 2.08B | 1.58B | 1.22B |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of EUR 4.39B by 8.53B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 50.57B | 48.59B | 39.96B | 36.30B | 30.23B | 27.27B | 24.04B | 21.68B | 18.20B | 17.21B |
| Current assets | 30.62B | 30.74B | 24.39B | 23.06B | 18.19B | 15.93B | 11.97B | 10.43B | 9.01B | 8.56B |
| Cash and equivalents | 12.92B | 12.74B | 7.00B | 7.27B | 6.95B | 6.05B | 3.53B | 3.12B | 2.26B | 2.91B |
| Total liabilities | 30.95B | 30.11B | 26.51B | 27.49B | 20.09B | 13.40B | 10.16B | 8.73B | 7.52B | 7.39B |
| Short-term debt | 1.68B | 1.01B | 100.00K | 746.20M | 509.10M | 15.40M | 1.10B | 187.90M | 25.20M | 247.67M |
| Long-term debt | 2.71B | 3.68B | 4.63B | 3.51B | 4.08B | 4.66B | 3.11B | 3.03B | 3.00B | 3.07B |
| Shareholder equity | 19.61B | 18.48B | 13.45B | 8.81B | 10.14B | 13.87B | 13.88B | 12.94B | 10.68B | 9.82B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 58.98B | 50.21B | 48.06B | 50.57B | 45.10B | 45.10B | 44.85B | 45.48B | 48.59B | 41.77B | 40.74B | 39.04B |
| Total liabilities | 36.92B | 28.39B | 27.23B | 30.95B | 26.10B | 26.10B | 27.23B | 27.98B | 30.11B | 25.61B | 26.03B | 25.25B |
| Cash and equivalents | 8.03B | 6.67B | 7.97B | 12.92B | 5.13B | 5.13B | 7.24B | 9.10B | 12.74B | 4.98B | 4.81B | 5.10B |
| Shareholder equity | 22.06B | 21.83B | 20.83B | 19.61B | 18.99B | 18.99B | 17.62B | 17.50B | 18.48B | 16.15B | 14.71B | 13.79B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 87.5% of operating cash flow. Dividends came to 23.0% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 12.66B | 11.17B | 5.44B | 8.49B | 10.85B | 4.63B | 3.28B | 3.30B | 1.80B | 1.67B |
| Capital expenditures | 1.57B | 2.08B | 2.20B | 1.28B | 900.70M | 962.00M | 766.60M | 838.30M | 358.00M | 324.70M |
| Free cash flow | 11.08B | 9.08B | 3.25B | 7.20B | 9.95B | 3.67B | 2.51B | 2.46B | 1.44B | 1.34B |
| Dividends paid | 2.55B | 2.45B | 2.35B | 2.56B | 1.37B | 1.07B | 1.33B | 597.10M | 516.70M | 445.90M |
| Investing cash flow | -3.78B | -2.61B | -2.69B | -1.03B | -72.00M | -1.35B | -1.16B | -720.30M | -1.21B | -3.19B |
| Financing cash flow | -8.67B | -2.83B | -3.00B | -7.19B | -9.89B | -753.00M | -1.79B | -1.72B | -1.21B | 1.96B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 11.80B | 1.70B | -2.19B | 11.41B | 559.10M | 559.10M | 1.35B | -58.60M | 9.54B | 949.90M | 923.40M | -251.90M |
| Capital expenditures | 413.30M | 299.40M | 422.30M | 447.90M | 315.40M | 315.40M | 988.30M | 416.50M | 705.50M | 415.80M | 538.00M | 423.80M |
| Free cash flow | 11.38B | 1.40B | -2.61B | 10.96B | 243.70M | 243.70M | 357.70M | -475.10M | 8.84B | 534.10M | 385.40M | -675.70M |
Frequently Asked Questions About ASML
What is ASML Holding N.V. New York Registry Shares' annual revenue?
ASML Holding N.V. New York Registry Shares reported revenue of EUR 32.67B for the fiscal year ended Dec 31, 2025.
How fast is ASML Holding N.V. New York Registry Shares' revenue growing?
Revenue was up 15.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 15.6%.
Is ASML Holding N.V. New York Registry Shares profitable?
Yes. ASML Holding N.V. New York Registry Shares reported net income of EUR 9.61B for the fiscal year ended Dec 31, 2025, with a net margin of 29.4%.
How much free cash flow does ASML generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of EUR 12.66B minus capital expenditures of EUR 1.57B produced free cash flow of EUR 11.08B.
How much debt does ASML Holding N.V. New York Registry Shares have?
The balance sheet dated Dec 31, 2025 reported long-term debt of EUR 2.71B, short-term debt of EUR 1.68B and cash and equivalents of EUR 12.92B.
ASML pages: Overview, Dividends, Financials, Valuation, Competitors